Science Explorer Interactive view Map
Company · Chappaqua · United States

BioTheryX (United States)

biotheryx.comROR OpenAlex
Research works
15
▲ 233% vs 2013–17
Citations
695
46.4 per fractional work
Top-10% rate
7.8%
record average 16.5%
Open access
22%
world 28%

Not ranked overall: BioTheryX (United States) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Which research topics does BioTheryX (United States) publish most on?

By volume in 2022–2025: Advanced Breast Cancer Therapies, Ubiquitin and proteasome pathways, Protein Degradation and Inhibitors and Cancer-related Molecular Pathways.

Advanced Breast Cancer T…2Advanced Breast Cancer Therapies: 2 fractional worksUbiquitin and proteasome…1Ubiquitin and proteasome pathways: 1 fractional worksProtein Degradation and …1Protein Degradation and Inhibitors: 1 fractional worksCancer-related Molecular Pathways: 0 fractional worksCancer Treatment and Pharmacology: 0 fractional worksDermatology and Skin Dis…0Dermatology and Skin Diseases: 0 fractional worksAcute Myeloid Leukemia Research: 0 fractional worksUrticaria and Related Conditions: 0 fractional worksPeptidase Inhibition and Analysis: 0 fractional worksMultiple Myeloma Research and Treatments: 0 fractional works
Pulmonary and Respiratory MedicineMolecular BiologyOncologyDermatology2 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Advanced Breast Cancer Therapies Pulmonary and Respiratory Medicine 2 works
  2. 2 Ubiquitin and proteasome pathways Molecular Biology 1 works
  3. 3 Protein Degradation and Inhibitors Molecular Biology 1 works
  4. 4 Cancer-related Molecular Pathways Oncology 0 works
  5. 5 Cancer Treatment and Pharmacology Oncology 0 works
  6. 6 Dermatology and Skin Diseases Dermatology 0 works
  7. 7 Acute Myeloid Leukemia Research Hematology 0 works
  8. 8 Urticaria and Related Conditions Rheumatology 0 works
  9. 9 Peptidase Inhibition and Analysis Oncology 0 works
  10. 10 Multiple Myeloma Research and Treatments Hematology 0 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available22.3%not open77.7%

World: 28% of research is openly available.

with international co-authors11.0%domestic only89.0%

World: 19% is written across borders.

How has BioTheryX (United States)'s research output changed?

Output in 2018–2022 was 233% higher than in 2013–2017.

201020152020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in Chappaqua

All research institutions in Chappaqua

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.